drugset / Trial / NCT00214578
Seroquel on Glucose Metabolism
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether six months treatment with the antipsychotic medicine Seroquel (quetiapine) may affect the schizophrenic patient's glucose metabolism
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- 2005-10
Outcome
Met primary endpoint
paper was significantly lower for quetiapine versus olanzapine (t = 1.98, df = 377, p = .048). PMID 19358783 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | — | — |